Methods of making iron-containing nanoparticles
A method of making iron-containing nanoparticles (e.g., magnetite nanoparticles) that includes contacting an iron-containing precursor with a reducing agent at a temperature less than 200° C. and allowing the mixture to react to form magnetite nanoparticles.
1. A method of making iron-containing nanoparticles, the method comprising:
contacting an iron-containing precursor with a reducing agent at a temperature less than 200° C. to form a mixture; and
allowing the mixture to react at a temperature less than 200° C. for a time sufficient to form magnetite nanoparticles, wherein the average size of the magnetite nanoparticles is at least 3 nanometers wherein the iron-containing precursor comprises iron(III) acetylacetonate.
2. The method of claim 1 , wherein the reducing agent comprises sodium borohydride.
3. The method of claim 1 , wherein the temperature during contacting is greater than 10° C.
4. The method of claim 1 , wherein the mixture further comprises a deoxygenated liquid and the contacting occurs in a deoxygenated atmosphere.
5. The method of claim 1 , wherein the average size of the magnetite nanoparticles is no greater than 12 nanometers.
6. The method of claim 1 , wherein contacting an iron-containing precursor with a reducing agent to form a mixture comprises:
preparing a composition comprising water, an alcohol, and the iron-containing precursor at a temperature of from greater than 10° C. to 85° C.; and
adding a reducing agent to the composition to form the mixture.
7. The method of claim 1 , wherein the molar ratio of the iron-containing precursor to the reducing agent is from 1:80 to less than 1:5.
8. The method of claim 1 , wherein the method further comprises collecting the magnetite nanoparticles with a magnet, washing the magnetite nanoparticles, and/or drying the magnetite nanoparticles.
9. The method of claim 1 , wherein the method further comprises
mixing the magnetite nanoparticles with a hydrophobic surfactant and a non-aqueous liquid to form magnetite nanoparticles that further comprise hydrophobic ligands.
10. The method of claim 9 , wherein mixing the magnetite nanoparticles with a hydrophobic surfactant and a non-aqueous liquid comprises sonicating the magnetite nanoparticles with a hydrophobic surfactant and a non-aqueous liquid.
11. The method of claim 1 , wherein the nanoparticle formation occurs in the absence of toxic organic surfactants.
12. The method of claim 1 , wherein the time sufficient to form magnetite nanoparticles is 30 minutes or less.
13. The method of claim 1 , wherein the magnetite nanoparticles are present in an amount of 50 weight percent (wt-%) or more relative to the total weight of nanoparticles formed.
14. A method of making selectively-sized iron-containing nanoparticles, the method comprising:
providing a composition comprising an iron-containing precursor;
adding a reducing agent to the composition to form selectively-sized magnetite nanoparticles, wherein the molar ratio of the iron-containing precursor to the reducing agent is from 1:80 to less than 1:5, wherein the reducing agent comprises sodium borohydride, and allowing the mixture to react at a temperature from greater than 10° C. to 90° C. for a time sufficient to form magnetite nanoparticles.
15. A method of making magnetite nanoparticles, the method comprising:
combining iron(III) acetylacetonate and deoxygenated ethanol with deoxygenated water to form a composition under a nitrogen atmosphere;
adding sodium borohydride to the composition at a temperature from greater than 10° C. to 90° C. to form a mixture;
allowing the mixture to react at a temperature from greater than 10° C. to 90° C. for a time sufficient to form magnetite nanoparticles.
16. The method of claim 15 , wherein the composition further comprises a surfactant, wherein the surfactant is not reduced under conditions of magnetite nanoparticle formation.
17. The method of claim 15 , wherein the composition further comprises a capping agent, wherein the capping agent is not reduced under conditions of magnetite nanoparticle formation.
18. The method of claim 17 , wherein the capping agent is selected from the group consisting of poly(ethylene glycol), oleic acid, L-glutamic acid, R-glutamic acid, L-arginine, and R-arginine.
19. A method comprising using the iron-containing nanoparticles made by the method of claim 1 as a magnetic resonance imaging contrast agent, in magnetically directed drug delivery, in a magnetic recording device, in tumour treatment by hyperthermia, or magnetic tagging of a cell, a virus, a protein, and/or a gene.